Enhanced Brain Delivery of Amino Acids and Peptides Through the Use of Redox Targeting Systems

作者: Marcus E. Brewster , Wesley R. Anderson , Nicholas Bodor

DOI: 10.1007/978-1-4615-3432-7_22

关键词: BiophysicsCell membraneAmino acidChemistryParenchymaMembraneNeuropeptidePhospholipidVesicular transport proteinCentral nervous systemBiochemistry

摘要: Many central diseases, including amino acid and neuropeptide deficiencies, are potentially treatable using replacement therapy. Unfortunately, delivery of the appropriate agents to nervous system is a highly complex undertaking due an interfacial barrier vascular derivative termed blood-brain (BBB).1–3 The cerebral microvasculature differs in several important respects from those capillaries present periphery. Firstly, endothelial cells which comprise microvessels tightly joined one another.4,5 This unique architecture prevents bulk movement materials between forces compounds diffuse directly through phospholipid cell membrane if they gain access brain parenchyma. Since only with sufficient affinity for lipid membranes will penetrate BBB, hydrophilic molecules, many drugs, excluded.6 Other distinguishing features that not fenestrated maintain vesicular transport relatively low activity. These functions substantially restrict generalized into CNS have clearly evolved protect delicate environment necessary optimal neural functioning.

参考文章(59)
JOSEPH JANKOVIC, Parkinson's disease: recent advances in therapy. Southern Medical Journal. ,vol. 81, pp. 1021- ,(1988) , 10.1097/00007611-198808000-00020
Hans Bundgaard, Design of prodrugs Elsevier , Sole distributors for the USA and Canada, Elsevier Science Pub. Co.. ,(1985)
B.S. Meldrum, Epilepsy and γ-Aminobutyric Acid-Mediated Inhibition International Review of Neurobiology. ,vol. 17, pp. 1- 36 ,(1975) , 10.1016/S0074-7742(08)60205-6
Nicholas Bodor, James J. Kaminski, Chapter 30 Prodrugs and Site-Specific Chemical Delivery Systems Annual Reports in Medicinal Chemistry. ,vol. 22, pp. 303- 313 ,(1987) , 10.1016/S0065-7743(08)61178-1
Edward E. Wallach, Samuel S.C. Yen, Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs. Fertility and Sterility. ,vol. 39, pp. 257- 266 ,(1983) , 10.1016/S0015-0282(16)46869-X
Donna L. Hammond, Intrathecal administration: methodological considerations. Progress in Brain Research. ,vol. 77, pp. 313- 320 ,(1988) , 10.1016/S0079-6123(08)62797-1